Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Can borderline homocysteine persist despite adequate serum folate and B12?

Yes, borderline homocysteine can persist even when serum folate and total vitamin B12 look adequate.

PlausibleAugust 21, 202613 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Homocysteine metabolism is influenced by interacting genetic, thyroid, renal, and B-vitamin cofactor factors, so a borderline elevation can persist even when serum folate and serum vitamin B12 look adequate.

laying out figure…
5 of 7 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says homocysteine is shaped by remethylation and transsulfuration pathways, not by serum folate or total B12 alone. It frames borderline elevation as something that can reflect genetic, thyroid, renal, or cofactor-related influences, including functional B12 issues despite apparently normal serum values.

Verified conclusion

Homocysteine is regulated by remethylation and transsulfuration pathways rather than by serum folate or total B12 alone. In a 71-year-old man with a borderline elevation, apparently adequate serum values therefore do not exclude physiologically relevant contributors.

Clinical and metabolic evidence

  • Genetics: MTHFR C677T reduces production of 5-methyl-THF needed to remethylate homocysteine to methionine. In one cohort (408 men, 346 women), TT versus CC men had mean homocysteine of 14.1 versus 12.0 µmol/L (P<0.001). Effects are stronger with poorer folate status; A1298C alone is usually not an important independent determinant.
  • Kidney function: Lower eGFR is consistently associated with higher homocysteine, including relatively preserved renal function—approximately 0.13 µmol/L higher homocysteine per 1-unit lower eGFR in a community estimate.
  • Thyroid status: Subclinical hypothyroidism is associated with a modest mean elevation (1.16 µmol/L in a meta-analysis of 12 observational studies), though this association varies and is partly entangled with renal function and vitamin status.

Mechanistic considerations

  • Folate and B12 support remethylation; B6 supports transsulfuration. Renal tubular cells dispose of much homocysteine through CBS-mediated transsulfuration, which can be impaired in kidney injury or CKD.
  • Normal total serum B12 does not exclude intracellular functional B12 deficiency. Elevated methylmalonic acid (MMA) supports this possibility, although reduced renal function can itself raise MMA.
  • Riboflavin-derived FAD is an MTHFR cofactor; riboflavin lowered homocysteine in MTHFR 677TT individuals, particularly with lower baseline riboflavin status.

Bottom line

  • Borderline homocysteine can plausibly persist despite normal serum folate and B12. Interpretation should incorporate eGFR, thyroid status, functional B12 assessment with MMA when results are discordant, and selected genetic/cofactor context rather than relying on serum folate and total B12 alone.

References

  1. Riboflavin and Methylenetetrahydrofolate Reductase - NCBI - NIH — ncbi.nlm.nih.gov ↗
  2. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  3. Associations between two common variants C677T and ... — pubmed.ncbi.nlm.nih.gov ↗
  4. Association Between Plasma Homocysteine Levels and Subclinical Hypothyroidism in Adult Subjects: A Meta-Analysis - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  5. Estimated Glomerular Filtration Rate, Nutritional Factors ... — onlinelibrary.wiley.com ↗
  6. Homocysteine and methionine metabolism in renal failure — cris.maastrichtuniversity.nl ↗
  7. Characterization of homocysteine metabolism in the rat kidney - PMC — pmc.ncbi.nlm.nih.gov ↗
  8. Why is homocysteine elevated in renal failure and what can be ... — academic.oup.com ↗
  9. [PDF] Test Ordering Guidelines for Suspected Vitamin B12 and Folate ... — documents.cap.org ↗
  10. Riboflavin Lowers Homocysteine in Individuals Homozygous for the ... — ahajournals.org ↗
  11. Homocysteine—a retrospective and prospective appraisal - Frontiers — frontiersin.org ↗
  12. Guidelines for Investigation and Management of Vitamin B12 and ... — hey.nhs.uk ↗
  13. Ischemia-reperfusion reduces cystathionine-β-synthase-mediated hydrogen sulfide generation in the kidney | American Journal of Physiology-Renal Physiology | American Physiological Society — journals.physiology.org ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→